You are viewing: India Elastomeric Infusion Pumps Market analysis

The India Elastomeric Infusion Pumps Market was valued at $29.9 Million in 2025 and projected to reach to $40 Million by 2030, representing a compound annual growth rate of CAGR 6.0%. India's elastomeric infusion pumps market is poised for sustained growth through 2030, driven by increasing healthcare expenditure, rising prevalence of chronic diseases, and expanding access to advanced medical devices in tier-2 and tier-3 cities.

India Elastomeric Infusion Pumps Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

India Elastomeric Infusion Pumps Market Trends and Insights

  • India's healthcare infrastructure modernization and rising demand for portable drug delivery systems are driving market expansion across hospitals, clinics, and home care settings.
  • The 6.0% compound annual growth rate reflects India's increasing adoption of advanced infusion technologies and growing patient populations requiring chronic disease management. India's elastomeric infusion pumps sector benefits from rising healthcare expenditure, expanding pharmaceutical manufacturing capabilities, and growing awareness of patient-centric drug delivery solutions.
  • Between 2025 and 2030, India is expected to witness accelerated market penetration driven by regulatory support and cost-effective manufacturing.
  • India's position as a global pharmaceutical hub further strengthens the elastomeric infusion pumps market, as domestic manufacturers scale production to meet both domestic and export demand. India's market dynamics are shaped by increasing prevalence of cancer, diabetes, and cardiovascular diseases requiring continuous infusion therapy.
  • India's healthcare providers are increasingly investing in elastomeric pump technology to improve patient outcomes and reduce hospital stays.
  • The forecast period through 2030 positions India as a key growth market within the Asia Pacific region for elastomeric infusion pump solutions..

Key Market Statistics

  • CAGR (2025-2030) CAGR 6.0%
  • Market Size, 2025 ~USD 29.9 Million
  • Forecast, 2030 ~USD 40 Million
  • Country India

India Elastomeric Infusion Pumps Market Overview

Market Valuation Growth :

India's elastomeric infusion pumps market is valued at USD 29.9 million in 2025, with a projected expansion to USD 40.0 million by 2030, representing a steady 6.0% CAGR driven by healthcare modernization initiatives.

Healthcare Infrastructure Expansion :

India's rapidly modernizing healthcare infrastructure, coupled with increased government investments in medical device adoption, is creating significant opportunities for elastomeric infusion pump manufacturers across urban and semi-urban regions.

Rising Portable Drug Delivery Demand :

Growing preference for portable and patient-friendly drug delivery systems in India's hospitals, clinics, and home care settings is accelerating market adoption, particularly for chronic disease management and oncology treatments.

Outpacing Global Growth :

India's 6.0% CAGR exceeds the global market growth rate of 5.3%, indicating stronger regional momentum and positioning India as a high-growth market within the elastomeric infusion pumps sector.

India Elastomeric Infusion Pumps Market Dynamics

  • The shift toward home-based care and outpatient treatment models is accelerating adoption of portable infusion solutions across India's diverse healthcare ecosystem. Government initiatives promoting medical device manufacturing and the growing middle-class population seeking quality healthcare are expected to further propel market expansion.
  • Strategic partnerships between domestic manufacturers and international players, combined with improving regulatory frameworks, will enhance product availability and affordability, solidifying India's position as a key growth market in the elastomeric infusion pumps sector..

Related Ecosystem

Key Takeaways

  • India's elastomeric infusion pumps market is valued at USD 29.9 million in 2025 and is forecast to reach USD 40.0 million by 2030, representing a 6.0% CAGR.
  • India's healthcare modernization and rising chronic disease prevalence are primary drivers of elastomeric infusion pump adoption across clinical and home care settings.
  • India's position as a global pharmaceutical manufacturing hub enables cost-effective production and export of elastomeric infusion pump solutions.
  • India's regulatory environment and healthcare infrastructure investments are expected to accelerate market growth through 2030.

Elastomeric Infusion Pumps Market Report Scope

Report Metric Details
Base Year 2025
Fastest Growing Segment HOME CARE SETTINGS (Setting)
Forecast Period 2025–2030
Growth Rate CAGR of 5.3% from 2025 to 2030
Largest Segment ACCESSORIES AND CONSUMABLES (Product)
Market Size Base Year (Billions) ~USD 1.15 (2025)
Revenue Forecast (Billions) ~USD 1.49 (2030)
Segments Covered Type, Application, End-Use Industry, Product, Setting

India Elastomeric Infusion Pumps Market Report Segmentation

5 segment dimensions are covered across the global market.

By Type

  • Continuous Rate
  • Variable Rate

By Application

  • Analgesia/Pain Management
  • Antibiotics
  • Chemotherapy
  • Chemotherapy/Oncology
  • Diabetes Management
  • Gastroenterology
  • Hematology
  • Other Applications
  • Pain Management
  • Pediatrics/Neonatology

By End-Use Industry

  • Ambulatory Surgical Centers (Ascs)
  • Homecare Settings
  • Hospitals
  • Other End-Use Industries

By Product

  • Accessories And Consumables
  • Devices

By Setting

  • Academic And Research Institutes
  • Ambulatory Care Settings
  • Home Care Settings
  • Hospitals

INDIA: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023–2030

Segment20232024202520262027202820292030CAGR (%)
AMBULATORY SURGICAL CENTERS (ASCS)6.717.047.467.918.398.899.429.996
HOMECARE SETTINGS6.46.767.217.688.198.739.39.926.6
HOSPITALS12.6913.2914.0614.8715.7216.6317.5818.595.7
OTHER END-USE INDUSTRIES1.031.071.131.191.251.321.391.465.3
TOTAL26.8328.1729.8631.6533.5535.5637.6939.966

Target Audience

  • Medical Device Manufacturers : Manufacturers need India-specific market data to assess market entry feasibility, competitive landscape, and growth potential for elastomeric infusion pump product lines in one of Asia's fastest-growing healthcare markets.
  • Healthcare Investors & PE Firms : Investment professionals require validated market sizing and CAGR data for India to evaluate portfolio opportunities, fund allocation decisions, and identify high-growth segments within the medical device sector.
  • Hospital & Healthcare Facility Operators : Healthcare administrators need market insights to understand procurement trends, supplier landscape, and technology adoption patterns for infusion pump systems across Indian healthcare institutions.
  • Distributors & Supply Chain Partners : Distribution networks require India market intelligence to forecast demand, optimize inventory planning, and identify growth opportunities across different healthcare settings and geographic regions.
  • Government & Policy Bodies : Healthcare policymakers and regulatory agencies need market data to inform medical device policies, procurement guidelines, and healthcare infrastructure development initiatives aligned with market realities.

Key Companies in the India Elastomeric Infusion Pumps Market

CompanyHQOwnershipStrongest segments
BAXTERUnited StatesPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
NIPROJapanPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
AVNSUnited StatesPrivate CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
WOOYOUNG MEDICAL CO., LTD.South KoreaPrivate CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Electronic Infusion Pumps (adjacent),
SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.ChinaPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Accessories & Disposables for Elastomeric Pumps,
AMBU A/SDenmarkPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
DAIKEN MEDICAL CO., LTD.JapanPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate / PCA Elastomeric Pumps,Chemotherapy Applications,

BAXTER

Baxter is a publicly traded American healthcare company founded in 1931 that employs 37,500 people. The company operates in the medical devices and pharmaceuticals sector.

NIPRO

Nipro is a Japanese public company founded in 1947 with 38,593 employees operating in the medical devices sector. The company serves global healthcare markets.

AVNS

AVNS is a privately held American company founded in 2014 with 2,287 employees. The company operates in the medical devices industry.

WOOYOUNG MEDICAL CO., LTD.

Wooyoung Medical Co., Ltd. is a privately held South Korean company founded in 1996. The company operates in the medical devices sector.

SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.

Shanghai Int Medical Instruments Co., Ltd. is a publicly traded Chinese medical device company founded in 2006 with 2,088 employees. The company serves the healthcare market.

AMBU A/S

Ambu A/S is a publicly traded Danish medical device company founded in 1937 with 5,200 employees. The company specializes in emergency and surgical equipment.

DAIKEN MEDICAL CO., LTD.

Daiken Medical Co., Ltd. is a publicly traded Japanese medical device company founded in 1968 with 185 employees. The company serves the healthcare industry.

Reasons to Buy this Report

  • Market Size & Growth Validation : Access precise market valuation data for India (USD 29.9M in 2025) with verified 6% CAGR projections through 2030, enabling accurate financial forecasting and investment decision-making specific to the Indian market.
  • Competitive Positioning Intelligence : Understand India's market dynamics relative to global trends (5.3% global CAGR), identifying competitive advantages and growth opportunities unique to the Indian elastomeric infusion pumps sector.
  • Segment & Application Insights : Gain detailed understanding of India-specific demand drivers across hospitals, clinics, and home care settings, enabling targeted product development and market entry strategies tailored to Indian healthcare infrastructure.
  • Regulatory & Infrastructure Context : Leverage India-specific insights on healthcare modernization initiatives, government policies, and infrastructure expansion trends that directly impact market growth and device adoption rates.
  • Strategic Market Entry Planning : Develop data-driven go-to-market strategies for India with clear market size benchmarks, growth trajectories, and regional demand patterns to optimize resource allocation and maximize ROI.

Frequently asked questions

What is the current market size of elastomeric infusion pumps in India?

India's elastomeric infusion pumps market was valued at USD 29.9 million in 2025 and is projected to grow to USD 40.0 million by 2030.

What is the expected growth rate for elastomeric infusion pumps in India?

India's elastomeric infusion pumps market is expected to grow at a compound annual growth rate (CAGR) of 6.0% from 2025 to 2030.

What factors are driving growth in India's elastomeric infusion pumps market?

India's market growth is driven by healthcare infrastructure modernization, rising chronic disease prevalence, increasing healthcare expenditure, and growing adoption of portable drug delivery systems.

Which applications dominate India's elastomeric infusion pumps market?

India's elastomeric infusion pumps are primarily used in cancer chemotherapy, diabetes management, cardiovascular disease treatment, and pain management across hospitals, clinics, and home care settings.

How does India's pharmaceutical manufacturing capability impact the elastomeric infusion pumps market?

India's position as a global pharmaceutical hub enables domestic manufacturers to produce cost-effective elastomeric infusion pumps for both domestic consumption and international export, strengthening market competitiveness.

RESEARCH METHODOLOGY

The study involved four major activities to estimate the current size of the global elastomeric infusion pumps market. Exhaustive secondary research was conducted to gather information on the market, the peer product market, and the parent product group market. The next step was to validate these findings, assumptions, and sizes with the industry experts across the value chain of elastomeric infusion pumps through primary research. The top-down and bottom-up approaches were employed to estimate the overall size of the elastomeric infusion pumps market. After that, market breakdown and data triangulation procedures were used to determine the size of different segments and sub-segments of the market.

Secondary Research

The market for companies offering elastomeric infusion pumps is determined by secondary data obtained from paid and unpaid sources, analyzing the product portfolios of major companies in the ecosystem, and evaluating companies based on their performance and quality. Various secondary sources, including Business Standard, Bloomberg, the World Bank, and Factiva, were consulted to identify and collect information for this study on the elastomeric infusion pumps market. During the secondary research process, various secondary sources were consulted to identify and collect information relevant to the study. Secondary sources included annual reports, press releases, investor presentations of door vendors, forums, certified publications, and white papers. The secondary research was utilized to gather critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from both market- and technology-oriented perspectives.

Primary Research

In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from several key companies and organizations operating in the elastomeric infusion pump market. After completing the market engineering process (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers derived. Primary research was also conducted to identify the segmentation types, industry trends, competitive landscape of elastomeric infusion pumps offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies. In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

The following is the breakdown of primary respondents:

Elastomeric Infusion Pumps Market

Notes: Other designations include sales, marketing, and product managers. Tier 1: >USD 1 Billion; Tier 2: USD 500 million–1 Billion; and Tier 3: < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down and bottom-up approaches were employed to estimate and validate the size of the global elastomeric infusion pumps market. These methods were also widely used to assess the size of various related market segments. The research methodology used to determine the market size included the following:

Elastomeric Infusion Pumps Market

Data Triangulation

After determining the overall market size using market size estimation processes, the market was segmented into several segments and subsegments. The data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Elastomeric infusion pumps are portable, non-electronic medical devices designed for the controlled delivery of drugs, such as analgesics, antibiotics, and chemotherapeutic agents, over a specified period. These devices utilize the elastic properties of specific elastomers to deliver accurate, continuous, or intermittent medication infusions without requiring batteries or external power sources. Elastomeric infusion pumps are recognized for their simplicity, reliability, and ease of use, making them suitable for use in hospital, outpatient, and home care environments. They are produced and tested in accordance with international medical device standards, including ISO 13485 for quality management, ISO 11608 for infusion device efficacy, and ASTM standards for elastomeric materials. The devices are extensively utilized in oncology, pain management, anesthesia, and palliative care, enhancing patient compliance, mobility, and safety. Elastomeric infusion pumps are crucial to the advancement of the field of patient-centered drug delivery and healthcare innovation, particularly in home healthcare and ambulatory care.

Stakeholders

  • Elastomeric infusion pump manufacturers
  • Raw material suppliers
  • Converters & processors
  • Distributors and traders
  • Industry associations and regulatory bodies
  • End users

Report Objectives

  • To define, describe, and forecast the size of the global elastomeric infusion pumps market, based on type, end-use industry, and region in terms of value and volume
  • To provide detailed information on the significant drivers, restraints, opportunities, and challenges influencing the market
  • To strategically analyze micromarkets concerning individual growth trends, prospects, and their contribution to the market
  • To assess the growth opportunities in the market for stakeholders and provide details on the competitive landscape for market leaders
  • To forecast the market size of segments and subsegments for North America, Europe, Asia Pacific, South America, and the Middle East & Africa
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • To analyze competitive developments such as acquisitions, expansions, partnerships, and agreements in the elastomeric infusion pumps market
  • To provide the impact of AI/Gen AI on the market

Get the Full Elastomeric Infusion Pumps Market Report

Full forecast, segment splits, and company analysis for all Elastomeric Infusion Pumps Market.

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
DMCA.com Protection Status